Clinical Trial Update: Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating concomitant cilostazol and probucol on biomarkers, endothelial function, and safety in peripheral artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• Cilostazol (Cilostazol)
• Probucol (Probucol)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Peripheral Artery Disease | Phase 2 | Status: COMPLETED